Adolescence

Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update

Retrieved on: 
Monday, April 1, 2024

KANSAS CITY, Kan., April 01, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced its financial results for the twelve months ended December 31, 2023, and provided a clinical and business update. Highlights include capital raised from multiple sources and the addition of three independent board members.

Key Points: 
  • “Our lead asset CTx-1301 continues to impress clinical investigators and key opinion leaders as we share our Phase 3 results.
  • These tailwinds put Cingulate in a position to obtain non-dilutive capital and expand our pipeline of assets.
  • Looking ahead, Cingulate has several financial instruments in place to raise additional capital while fighting to preserve shareholder’s equity.
  • “Overall, I am very pleased with the progress made by our team in 2023 and into 2024.

Unity Consortium Marks Adolescent Immunization Action Week (AIAW) with activities to help Parents and Adolescents get up to date on Recommended Vaccines

Retrieved on: 
Thursday, March 28, 2024

AIAW is a national movement aimed at parents, adolescents and healthcare providers to ensure adolescents are up to date on well visits and recommended vaccines.

Key Points: 
  • AIAW is a national movement aimed at parents, adolescents and healthcare providers to ensure adolescents are up to date on well visits and recommended vaccines.
  • Across the nation, organizations interested in the health of adolescents are participating in AIAW to help protect adolescents from vaccine-preventable illnesses.
  • To address these challenges, Unity wants parents to help adolescents and young adults stay healthy by Staying on TASK with vaccines.
  • As AIAW kicks off, Unity offers activities and resources to support Adolescent Immunization Action Week efforts, including:
    A graphic and video animation of Staying on TASK.

Bryant University launches its first doctoral program: Doctor of Clinical Psychology (Psy.D.)

Retrieved on: 
Tuesday, March 26, 2024

Smithfield, RI, March 26, 2024 (GLOBE NEWSWIRE) -- Bryant University is introducing a Doctor of Clinical Psychology (Psy.D.)

Key Points: 
  • Smithfield, RI, March 26, 2024 (GLOBE NEWSWIRE) -- Bryant University is introducing a Doctor of Clinical Psychology (Psy.D.)
  • students can opt to specialize in one of two concentrations: Child and Adolescent Psychology and Health Psychology.
  • In addition to the crucial clinical focus, a Doctoral Research Project is a core part of Bryant’s Psy.D.
  • For more information on Bryant’s new Doctor of Clinical Psychology program, visit Bryant.edu/Psyd

Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards

Retrieved on: 
Tuesday, March 26, 2024

FREMONT, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics today announced the appointment of Hubert Chen, M.D., MPH, as Chief Medical Officer, effective March 21, 2024. Dr. Chen brings extensive clinical and industry leadership experience in drug development and joins Attovia from Krystal Biotech (NASDAQ: KRYS), where he was Senior Vice President of Clinical Development. At Attovia, Dr. Chen will lead the company’s clinical development and regulatory functions and will serve on the Executive Committee.

Key Points: 
  • Dr. Chen brings extensive clinical and industry leadership experience in drug development and joins Attovia from Krystal Biotech (NASDAQ: KRYS), where he was Senior Vice President of Clinical Development.
  • At Attovia, Dr. Chen will lead the company’s clinical development and regulatory functions and will serve on the Executive Committee.
  • Prior to Krystal, Dr. Chen was at Genentech/Roche where he held clinical leadership positions across both early and late-stage development.
  • To support the ongoing strategic development of the Attobody platform and advancement of the Company’s emerging pipeline candidates, Attovia has established Clinical and Scientific Advisory Boards comprised of biopharmaceutical industry veterans and academic experts.

Robins Kaplan LLP Files Complaint Against Social Media Giants Meta, Snap, TikTok on Behalf of Spirit Lake Nation, Menominee Indian Tribe of Wisconsin

Retrieved on: 
Tuesday, April 9, 2024

Today, Robins Kaplan LLP filed a first-of-its-kind lawsuit on behalf of the Spirit Lake Tribe in North Dakota and the Menominee Indian Tribe of Wisconsin against entities that include Facebook and Instagram parent company Meta Platforms, Inc., Snap Inc., TikTok parent company ByteDance, and Alphabet Inc., which owns YouTube and Google.

Key Points: 
  • Today, Robins Kaplan LLP filed a first-of-its-kind lawsuit on behalf of the Spirit Lake Tribe in North Dakota and the Menominee Indian Tribe of Wisconsin against entities that include Facebook and Instagram parent company Meta Platforms, Inc., Snap Inc., TikTok parent company ByteDance, and Alphabet Inc., which owns YouTube and Google.
  • The complaint alleges that rampant social media addiction for Native American teenagers is contributing to suicide rates that are staggeringly higher than their adolescent counterparts.
  • The Center for Native American Youth notes that Tribal teen suicide rates are roughly 3.5 times higher than the national average in the United States.
  • We are demanding these social media corporations take responsibility for intentionally creating dangerous features that ramp up the compulsive use of social media by the youth on our Reservation.”
    The complaint details how U.S.

Grow Therapy Raises $88M Sequoia Capital-Led Series C to Advance Effective Mental Healthcare

Retrieved on: 
Monday, April 8, 2024

NEW YORK, April 8, 2024 /PRNewswire/ -- Grow Therapy, a provider-centric mental health technology company improving access to high-quality mental healthcare, today announced the closing of its $88 million Series C investment round led by Sequoia Capital, with support from Growth Equity at Goldman Sachs Alternatives and PLUS Capital alongside artists and athletes from their collective including Anna Kendrick, Lily Collins, Dak Prescott, Joe Burrow, Jrue Holiday, and Lauren Holiday. Existing investors Transformation Capital, SignalFire and TCV also participated in the round. Additionally, the company announced the launch of its enhanced measurement-informed care system, which will allow it to elevate the care experience for clients and providers and make value-based behavioral care accessible for all patient populations, including Medicaid and Medicare members.

Key Points: 
  • Empowering people to find and engage with effective mental health support is the most pressing need of our time.
  • Grow Therapy CEO Jake Cooper said, "Our team believes that empowering people to find and engage with effective mental health support – regardless of their background, geography or financial circumstances – is the most pressing need of our time.
  • We're proud to partner with the Grow Therapy team as they pursue the important mission of providing access to trusted mental healthcare."
  • Grow Head of Clinical Excellence Cynthia Grant PhD, LCSW, concluded, "Our team at Grow Therapy is privileged to have the opportunity every day to build the infrastructure for this new age of mental healthcare.

Lost for words? Research shows art therapy brings benefits for mental health

Retrieved on: 
Tuesday, April 9, 2024

Art therapy uses creative processes, primarily visual art such as painting, drawing or sculpture, with a view to improving physical health and emotional wellbeing.

Key Points: 
  • Art therapy uses creative processes, primarily visual art such as painting, drawing or sculpture, with a view to improving physical health and emotional wellbeing.
  • Art therapy can be used to support treatment for a wide range of physical and mental health conditions.
  • In a study published this week in the Journal of Mental Health, we found art therapy was associated with positive outcomes for children and adolescents in a hospital-based mental health unit.

An option for those who can’t find the words

  • Where possible, after finishing an artwork, a person can explore the meaning of their work with the art therapist, translating unspoken symbolic material into verbal reflection.
  • However, as the talking component is less central to the therapeutic process, art therapy is an accessible option for people who may not be able to find the words to describe their experiences.
  • Art therapy has also been linked to improved outcomes for people with a range of physical health conditions.

Our research

  • While most care takes place in the community, a small proportion of young people require care in hospital to ensure their safety.
  • However, these “restrictive practices” are associated with negative effects such as post-traumatic stress for patients and health professionals.
  • Read more:
    'An arts engagement that's changed their life': the magic of arts and health

    Our research looked at more than six years of data from a child and adolescent mental health hospital ward in Australia.

  • Confirming the effect of a therapeutic intervention requires controlled clinical trials where people are randomly assigned one treatment or another.
  • Although ours was an observational study, randomised controlled trials support the benefits of art therapy in youth mental health services.

What do young people think?

  • In previous research we found art therapy was considered by adolescents in hospital-based mental health care to be the most helpful group therapy intervention compared to other talk-based therapy groups and creative activities.
  • In research not yet published, we’re speaking with young people to better understand their experiences of art therapy, and why it might reduce distress.

A promising area


The burgeoning research showing the benefits of art therapy for both physical and especially mental health highlights the value of creative and innovative approaches to treatment in health care. There are opportunities to expand art therapy services in a range of health-care settings. Doing so would enable greater access to art therapy for people with a variety of physical and mental health conditions.

  • She has received funding from the Health Education and Training Institute (HETI) for the Mental Health Research Award.
  • Iain Perkes works for the University of New South Wales and the Sydney Children's Hospitals Network which is part of NSW Health.
  • He is affiliated with Neuroscience Research Australia (NeuRA) and the Health Education and Training Institute (HETI, NSW Health).

Social media will tell you birth control causes mental health issues, weight gain and infertility – here are the facts

Retrieved on: 
Tuesday, April 9, 2024

Some women are reportedly even stopping their birth control as a result of misleading posts they’ve seen on TikTok and Instagram.

Key Points: 
  • Some women are reportedly even stopping their birth control as a result of misleading posts they’ve seen on TikTok and Instagram.
  • These three common misconceptions about birth control are cropping up online and need to be put in context:

1. Contraception causes depression

  • Countless videos on social media discuss the effect hormonal contraceptives have on mental health – with some creators claiming birth control causes mood changes and even depression.
  • Although there’s some correlation between mental health and some forms of contraception, there are many factors at play.
  • The articles in this series explore the questions and bring answers as we navigate this turbulent period of life.
  • The evidence suggests depression is more common in adolescent girls – and diminishes after the first two years of taking these forms of birth control.
  • At present, there’s little conclusive evidence that contraception (both hormonal and non-hormonal types) cause mental health problems.

2. Contraception causes weight gain

  • Another common social media claim is that birth control causes weight gain.
  • There is one form of contraception that is linked to weight gain.
  • The Depo-Provera injection, which is administered every 12 weeks, has been proved to cause weight gain.


This weight gain may be due to the progesterone in the shot, which can cause people to feel hungrier – potentially leading to overeating and weight gain. If you’re concerned about potential weight gain, the injection is not the only form of contraception available. Other forms of hormonal and non-hormonal contraceptives have not been shown to affect your weight.

3. Birth control lowers your fertility

  • Another common claim on social media is that birth control causes fertility issues.
  • Research shows hormonal contraceptives have no affect on fertility.
  • Again, evidence shows that IUDs pose no risk to fertility.
  • A systematic review reports no specific differences in fertility between hormonal and non-hormonal IUDs.


Christopher O'Sullivan does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Orphan designation: idebenone Treatment of Leber's hereditary optic neuropathy, 16/02/2007 Positive

Retrieved on: 
Tuesday, April 9, 2024

Orphan designation: idebenone Treatment of Leber's hereditary optic neuropathy, 16/02/2007 Positive

Key Points: 


Orphan designation: idebenone Treatment of Leber's hereditary optic neuropathy, 16/02/2007 Positive

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

Retrieved on: 
Monday, March 25, 2024

NeuroStar is the first and only transcranial magnetic stimulation (TMS) treatment FDA-cleared for this age group, making it the fourth FDA-cleared indication for NeuroStar.

Key Points: 
  • NeuroStar is the first and only transcranial magnetic stimulation (TMS) treatment FDA-cleared for this age group, making it the fourth FDA-cleared indication for NeuroStar.
  • "The prevalence of depression in adolescents and young adults has been accelerating since the COVID-19 pandemic.
  • "NeuroStar’s TMS therapy now offers a promising first-line treatment for adolescents, backed by real-world data and impressive response rates consistent with response rates for adults.
  • This advancement has the potential to set a new treatment paradigm for how we address depression in our youth."